Products
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 2.32 | - |
NAV | ₹14.19 | - |
Fund Started | 13 Mar 2023 | - |
Fund Size | ₹297.86 Cr | - |
Exit Load | - | - |
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹500
-
Expense Ratio
2.32
-
NAV
₹14.19
-
Fund Started
13 Mar 2023
-
Fund Size
₹297.86 Cr
-
Exit Load
-
-
Returns
1 Year | -4.51% | - |
3 Year | - | - |
5 Year | - | - |
1 Year
-4.51%
-
3 Year
-
-
5 Year
-
-
Holding Analysis
Equity | 98.11% | - |
Cash | 0.09% | - |
Equity
98.11%
-
Cash
0.09%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Polycab India Ltd. | 5.24% |
HDFC Asset Management Company Ltd. | 5.10% |
Metropolis Healthcare Ltd. | 4.82% |
Muthoot Finance Ltd. | 4.79% |
Dr. Lal Pathlabs Ltd. | 4.66% |
Coromandel International Ltd. | 4.20% |
Gillette India Ltd. | 4.14% |
Alkem Laboratories Ltd. | 4.12% |
Marico Ltd. | 3.96% |
Mphasis Ltd. | 3.93% |
-
Fund Manager
Name | Dhaval Patel | - |
Start Date | 08 Mar 2023 | - |
Name
Dhaval Patel
-
Start Date
08 Mar 2023
-
About Fund
Description | The Scheme seeks to generate income and long-term capital appreciation from a diversified portfolio of predominantly equity and equity-related instruments. | - |
Launch Date | 13 Mar 2023 | - |
Description
The Scheme seeks to generate income and long-term capital appreciation from a diversified portfolio of predominantly equity and equity-related instruments.
-
Launch Date
13 Mar 2023
-